程序性死亡受体1抑制剂导致重症免疫相关性 肺炎合并呼吸衰竭 1 例.Published in:Journal of Modern Medicine & Health, 2024, v. 40, n. 9, p. 1613, doi. 10.3969/j.issn.1009-5519.2024.09.040By:荆 科;郭 阳;白丽娜;周越塑;许 彪Publication type:Article